Boardroom Alpha
Boardroom Alpha
RIG · Current Report (Form 8-K) · Filed May 26, 2026

Transocean Ltd — Current Report (Form 8-K)

Form
8-K
Filed
May 26, 2026
Period
May 22, 2026
Ticker
RIG
Accession
0001451505-26-000049
Boardroom Alpha · Filing insights

AGM approved issuing up to 240,801,936 shares; Finance Committee dissolved; board leadership and directors elected.

About Transocean Ltd
Market cap
$7.0B
1Y TSR
+133.6%
3Y TSR
+2.2%
Board grade
C
Sector
Energy
CEO
Keelan Adamson
Last annual meeting: May 22, 2026 · View full Transocean Ltd profile →
TRANSOCEAN LTD_May 22, 2026

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of report (date of earliest event reported): May 26, 2026 (May 22, 2026)

TRANSOCEAN LTD.

(Exact name of Registrant as specified in its charter)

Switzerland

  ​ ​ ​

001-38373

  ​ ​ ​

98-0599916

(State or other jurisdiction of

(Commission

(I.R.S. Employer

incorporation or organization)

File Number)

Identification No.)

Turmstrasse 30

  ​ ​

Steinhausen, Switzerland

CH-6312

(Address of principal executive offices)

(zip code)

Registrant’s telephone number, including area code: +41 (41749-0500

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act

Title of each class

Trading Symbol

Name of each exchange on which registered:

Shares, $0.10 par value

RIG

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 3.02Unregistered Sales of Equity Securities.

The information included under Item 5.03 is incorporated herein by reference.

Item 5.03Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

General Capital Authorization

At the 2026 Annual General Meeting of Shareholders of Transocean Ltd. (the “Company”) held on May 22, 2026 (the “AGM”) in Zug, Switzerland, shareholders of the Company approved an amendment to the Articles of Association of the Company to permit the issuance of up to 240,801,936 shares, par value U.S. $0.10 per share (“Shares”), for a term expiring on May 22, 2027. In connection with the foregoing, the Articles of Association of the Company were further amended to reflect changes in the Company’s total issued share capital resulting from the issuance of 100,000,000 Shares into treasury pursuant to the general capital authorization approved at the AGM. The Company’s Articles of Association now reflect a share capital of U.S. $130,400,968.10 divided into 1,304,009,681 fully paid registered Shares.

The issuance of Shares into treasury described above is intended to allow the Company to timely deliver Shares from time to time pursuant to the general capital authorization approved by the Company’s shareholders and is exempt pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended, which exempts transactions by an issuer not involving a public offering.

The foregoing description of the Articles of Association does not purport to be complete and is qualified in its entirety by reference to the full text of the Articles of Association, amended as of May 22, 2026, a copy of which is filed herewith as Exhibit 3.1 and is incorporated herein by reference

Finance Committee Dissolution

At its meeting on May 22, 2026, the Board of Directors of the Company approved an amendment to the Organizational Regulations, to be effective as of July 1, 2026, (as amended, the “Organizational Regulations”) to reflect the dissolution of the Finance Committee.

The foregoing description of the Organizational Regulations does not purport to be complete and is qualified in its entirety by reference to the full text of the Organizational Regulations, a copy of which is filed herewith as Exhibit 3.2 and is incorporated herein by reference

.

Item 5.07Submission of Matters to a Vote of Security Holders.

At the AGM, shareholders of the Company took action on the following matters:

1.(A) Proposal regarding the approval of the 2025 Annual Report, including the Audited Consolidated Financial Statements of the Company. for Fiscal Year 2025 and the Audited Statutory Financial Statements of the Company for Fiscal Year 2025.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

 

750,552,296

2,419,638

2,287,396

This item was approved.

1.(B) Proposal regarding the advisory vote to approve the Company’s Swiss Statutory Compensation Report for Fiscal Year 2025.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

  ​ ​ ​

Broker Non-Votes

 

594,938,365

32,140,199

1,896,023

126,284,743

This item was approved.

1.(C) Proposal regarding the advisory vote to approve the Company’s Swiss Statutory Report on Non-Financial Matters Report for Fiscal Year 2025.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

 

747,518,602

4,689,582

3,051,146

This item was approved.

2.Proposal regarding the discharge of the Members of the Board of Directors and the Executive Management Team from liability for activities during Fiscal Year 2025.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

  ​ ​ ​

Broker Non-Votes

 

598,427,310

16,840,333

13,706,944

126,284,743

This item was approved.

3.Proposal regarding the Appropriation of the Accumulated Losses for Fiscal Year 2025.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

 

736,519,216

15,910,244

2,829,870

This item was approved.

4.Proposal regarding the approval of Shares authorized for issuance.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

 

689,986,288

25,485,761

39,787,281

This item was approved.

5.Proposals regarding the election of 11 directors, each for a term extending until completion of the next Annual General Meeting.

16,971,385

Name of Nominee for Director

  ​ ​

For

  ​ ​

Against

  ​ ​

Abstain

  ​ ​

Broker Non-Votes

 

5A

  ​ ​

Keelan I. Adamson

610,939,692

16,971,385

1,063,510

126,284,743

5B

Glyn A. Barker

605,583,920

22,325,035

1,065,632

126,284,743

5C

Vanessa C.L. Chang

606,554,128

21,363,480

1,056,979

126,284,743

5D

Frederico F. Curado

536,924,649

90,952,788

1,097,150

126,284,743

5E

Chadwick C. Deaton

607,198,359

20,752,986

1,023,242

126,284,743

5F

Domenic J. “Nick” Dell’Osso, Jr.

593,908,354

34,037,097

1,029,136

126,284,743

5G

Vincent J. Intrieri

609,117,881

18,811,363

1,045,343

126,284,743

5H

William F. “Bill” Lacey

612,006,783

16,028,196

939,608

126,284,743

5I

Samuel J. Merksamer

607,175,019

20,774,960

1,024,608

126,284,743

5J

Frederik W. Mohn

593,666,633

34,212,298

1,095,656

126,284,743

5K

Jeremy D. Thigpen

605,594,445

22,435,501

944,641

126,284,743

Each of the 11 persons listed above was duly elected as a director of the Company to hold office until the completion of the next Annual General Meeting.

6.Proposal regarding the election of the Chair of the Board of Directors for a term extending until completion of the next Annual General Meeting.

Name of Chair Nominee

  ​ ​ ​

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

  ​ ​ ​

Broker Non-Votes

 

Jeremy D. Thigpen

605,505,060

22,409,695

1,059,832

126,284,743

Jeremy D. Thigpen was elected Chair of the Board of Directors of the Company to hold office until the completion of the next Annual General Meeting.

7.Proposal regarding the election of the members of the Compensation Committee, each for a term extending until completion of the next Annual General Meeting.

Name of Compensation Committee Nominee

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

  ​ ​ ​

Broker Non-Votes

 

Glyn A. Barker

605,476,279

22,346,063

1,152,245

126,284,743

Vanessa C.L. Chang

606,659,268

21,153,557

1,161,762

126,284,743

Frederico F. Curado

547,602,610

80,174,728

1,197,249

126,284,743

Each of the three persons listed above was duly elected to serve as a member of the Compensation Committee of the Company to hold office until completion of the next Annual General Meeting.  

8.Proposal regarding the reelection of the independent proxy for a term extending until completion of the next Annual General Meeting.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

 

748,971,747

4,256,253

2,031,330

This item was approved.

9.Proposal regarding the ratification of Ernst & Young LLP as the Company’s Independent Registered Public Accounting Firm for Fiscal Year 2026 and reelection of Ernst & Young Ltd, Zurich, as the Company’s Auditor for a further one-year term.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

 

692,652,694

61,460,892

1,145,744

This item was approved.

10.Proposal regarding the advisory vote to approve Named Executive Officer compensation for Fiscal Year 2026.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

  ​ ​ ​

Broker Non-Votes

 

486,932,557

102,138,948

39,903,082

126,284,743

This item was approved.

 

11.(A) Proposal regarding the ratification of the maximum aggregate amount of compensation of the Board of Directors for the period between the 2026 Annual General Meeting and the 2027 Annual General Meeting.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

  ​ ​ ​

Broker Non-Votes

 

610,150,514

16,616,139

2,207,934

126,284,743

This item was approved.

11.(B) Proposal regarding the ratification of the maximum aggregate amount of compensation of the Executive Management Team for Fiscal Year 2027.

For

  ​ ​ ​

Against

  ​ ​ ​

Abstain

  ​ ​ ​

Broker Non-Votes

 

608,443,687

18,272,663

2,258,237

126,284,743

This item was approved.

For information regarding the applicable quorum and vote standard required to vote upon and pass each matter described in this Item 5.07, please refer to the sections of the Company’s definitive proxy statement for the AGM, under the headings: “Quorum” and “Votes Required.”

Item 9.01Financial Statements and Exhibits.

(d)  Exhibits.

Exhibit No.

  ​ ​ ​

Description

3.1

Articles of Association of Transocean Ltd., amended as of May 22, 2026

3.2

Organizational Regulations, as amended, to be effective as of July 1, 2026

101

Interactive data files pursuant to Rule 405 of Regulation S-T formatted in Inline Extensible Business Reporting Language

104

Cover Page Interactive Data File (formatted as inline XBRL).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

TRANSOCEAN LTD.

Date: May 26, 2026

By:

/s/ Debra Kupferman

Debra Kupferman

Authorized Person

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Transocean Ltd (RIG)

Reference

Frequently asked questions

When did Transocean Ltd file this 8-K?
Transocean Ltd (RIG) filed this Current Report (Form 8-K) with the SEC on May 26, 2026. The accession number assigned by EDGAR is 0001451505-26-000049.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
AGM approved issuing up to 240,801,936 shares; Finance Committee dissolved; board leadership and directors elected. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Transocean Ltd's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Transocean Ltd has filed under CIK 1451505, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer